Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
IFN The India Fund Inc
PMD Psychemedics Corp
BSL Blackstone/GSO Senior Floating Rate Term Fund
WFC Wells Fargo & Co
BKSSF Baker Steel Resources Trust Ltd
XDRC Xedar Corp
CHE Chemed Corp
TBIOD Transgenomic Inc
NISTF Nippon Steel & Sumitomo Metal Corp
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases. It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne muscular dystrophy (DMD). It is focused on the development of its disease-modifying DMD drug candidates. It has received accelerated approval for its product, EXONDYS 51, indicated for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. EXONDYS 51 is studied in clinical trials under the name of eteplirsen. Its next generation phosphorodiamidate morpholino oligomer (PMO)-based compounds are synthetic compounds that bind to complementary sequences of RNA by standard Watson-Crick nucleobase pairing. Its PMO-based chemistries are peptide conjugated PMO (PPMO), PMO-X and PMOplus.

Price
Delayed
$33.20
Day's Change
0.17 (0.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
33.67
Day's Low
32.36
Volume
(Light)

Today's volume of 293,578 shares is on pace to be much lighter than SRPT's 10-day average volume of 1,585,228 shares.

293,578
  • Prev Close
    33.03
  • Today's Open
    33.50
  • Day's Range
    32.36-33.67
  • Avg Vol (10-day)
    1.6M
  • Last (time)
    11:38a ET 06/28/17
  • Last (size)
    100
  • 52-Wk Range
    17.05 - 63.73
    LowHigh
  • (06/28/16 - 09/28/16)
    94.72%
  • 84.4%
  • Market Cap
    1.8B
  • Shares Outstanding
    55.0M
  • -2.64
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.2
  • 73.03
  • (% of float 06/15/17)
    24.77

Latest News

Today's News, June 28, 2017
8:30 am ET
Globe Newswire
Yesterday's News, June 27, 2017
8:30 am ET
Globe Newswire
June 23, 2017
6:00 am ET
PR Newswire
June 21, 2017
1:30 pm ET
BusinessWire
7:00 am ET
Globe Newswire
May 31, 2017
6:30 pm ET
Globe Newswire
May 30, 2017
8:30 am ET
Globe Newswire
May 01, 2017
5:30 pm ET
Globe Newswire
April 27, 2017
4:01 pm ET
Globe Newswire
April 18, 2017
11:20 am ET
PR Newswire
April 17, 2017
8:30 am ET
Globe Newswire
April 07, 2017
7:00 am ET
PR Newswire
April 05, 2017
5:00 pm ET
Globe Newswire
April 03, 2017
8:30 am ET
Globe Newswire
March 31, 2017
6:30 pm ET
Globe Newswire
March 30, 2017
8:30 am ET
Globe Newswire
February 13, 2017
4:12 pm ET
MarketWatch
4:02 pm ET
MarketWatch
February 09, 2017
3:51 pm ET
MarketWatch
January 19, 2017
9:08 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2017 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , , and

Copyright © 2017. All rights reserved.